vs
布鲁克（BRKR）与RAPID MICRO BIOSYSTEMS, INC.（RPID）财务数据对比。点击上方公司名可切换其他公司
布鲁克的季度营收约是RAPID MICRO BIOSYSTEMS, INC.的86.6倍（$977.2M vs $11.3M）。布鲁克净利率更高（2.7% vs -110.8%，领先113.4%）。RAPID MICRO BIOSYSTEMS, INC.同比增速更快（37.3% vs -0.2%）。布鲁克自由现金流更多（$207.2M vs $-3.3M）。过去两年RAPID MICRO BIOSYSTEMS, INC.的营收复合增速更高（41.8% vs 16.4%）
布鲁克公司是美国科学仪器制造商，总部位于马萨诸塞州比勒里卡，为公开上市企业。公司产品服务于分子与材料研究、工业及应用分析领域，旗下设有布鲁克科学仪器、布鲁克能源与超导技术（BEST）两大业务板块。
RAPID MICRO BIOSYSTEMS, INC. 是生命科学领域的技术企业，专注于为生物制药厂商、合同研发生产机构等客户提供自动化微生物检测及质控解决方案，可大幅缩短检测周期、提升检测精度，业务覆盖北美、欧洲、亚太等全球核心市场。
BRKR vs RPID — 直观对比
营收规模更大
BRKR
是对方的86.6倍
$11.3M
营收增速更快
RPID
高出37.5%
-0.2%
净利率更高
BRKR
高出113.4%
-110.8%
自由现金流更多
BRKR
多$210.5M
$-3.3M
两年增速更快
RPID
近两年复合增速
16.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $977.2M | $11.3M |
| 净利润 | $26.0M | $-12.5M |
| 毛利率 | 46.0% | — |
| 营业利润率 | 7.8% | -108.2% |
| 净利率 | 2.7% | -110.8% |
| 营收同比 | -0.2% | 37.3% |
| 净利润同比 | 89.8% | -29.3% |
| 每股收益（稀释后） | $0.10 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRKRRPID
| Q4 25 | $977.2M | $11.3M | ||
| Q3 25 | $860.5M | $7.8M | ||
| Q2 25 | $797.4M | $7.3M | ||
| Q1 25 | $801.4M | $7.2M | ||
| Q4 24 | $979.6M | $8.2M | ||
| Q3 24 | $864.4M | $7.6M | ||
| Q2 24 | $800.7M | $6.6M | ||
| Q1 24 | $721.7M | $5.6M |
净利润BRKRRPID
| Q4 25 | $26.0M | $-12.5M | ||
| Q3 25 | $-59.6M | $-11.5M | ||
| Q2 25 | $7.6M | $-11.9M | ||
| Q1 25 | $17.4M | $-11.3M | ||
| Q4 24 | $13.7M | $-9.7M | ||
| Q3 24 | $40.9M | $-11.3M | ||
| Q2 24 | $7.6M | $-12.6M | ||
| Q1 24 | $50.9M | $-13.3M |
毛利率BRKRRPID
| Q4 25 | 46.0% | — | ||
| Q3 25 | 44.1% | — | ||
| Q2 25 | 44.9% | — | ||
| Q1 25 | 48.8% | — | ||
| Q4 24 | 50.4% | — | ||
| Q3 24 | 48.4% | — | ||
| Q2 24 | 48.0% | — | ||
| Q1 24 | 48.9% | — |
营业利润率BRKRRPID
| Q4 25 | 7.8% | -108.2% | ||
| Q3 25 | -6.0% | -145.1% | ||
| Q2 25 | 1.5% | -167.3% | ||
| Q1 25 | 4.0% | -161.8% | ||
| Q4 24 | 7.4% | -124.5% | ||
| Q3 24 | 7.9% | -158.3% | ||
| Q2 24 | 6.0% | -202.1% | ||
| Q1 24 | 9.0% | -254.4% |
净利率BRKRRPID
| Q4 25 | 2.7% | -110.8% | ||
| Q3 25 | -6.9% | -146.8% | ||
| Q2 25 | 1.0% | -163.3% | ||
| Q1 25 | 2.2% | -156.3% | ||
| Q4 24 | 1.4% | -117.6% | ||
| Q3 24 | 4.7% | -148.9% | ||
| Q2 24 | 0.9% | -190.1% | ||
| Q1 24 | 7.1% | -237.4% |
每股收益（稀释后）BRKRRPID
| Q4 25 | $0.10 | $-0.26 | ||
| Q3 25 | $-0.41 | $-0.26 | ||
| Q2 25 | $0.05 | $-0.27 | ||
| Q1 25 | $0.11 | $-0.26 | ||
| Q4 24 | $0.09 | $-0.22 | ||
| Q3 24 | $0.27 | $-0.26 | ||
| Q2 24 | $0.05 | $-0.29 | ||
| Q1 24 | $0.35 | $-0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $298.8M | $20.0M |
| 总债务越低越好 | $1.9B | — |
| 股东权益账面价值 | $2.5B | $33.2M |
| 总资产 | $6.2B | $74.9M |
| 负债/权益比越低杠杆越低 | 0.76× | — |
8季度趋势，按日历期对齐
现金及短期投资BRKRRPID
| Q4 25 | $298.8M | $20.0M | ||
| Q3 25 | $293.1M | $18.9M | ||
| Q2 25 | $92.0M | $18.3M | ||
| Q1 25 | $184.2M | $18.9M | ||
| Q4 24 | $183.4M | $16.9M | ||
| Q3 24 | $148.1M | $22.0M | ||
| Q2 24 | $169.7M | $37.1M | ||
| Q1 24 | $340.1M | $22.4M |
总债务BRKRRPID
| Q4 25 | $1.9B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.4B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.2B | — | ||
| Q1 24 | $1.4B | — |
股东权益BRKRRPID
| Q4 25 | $2.5B | $33.2M | ||
| Q3 25 | $2.4B | $44.3M | ||
| Q2 25 | $1.8B | $54.5M | ||
| Q1 25 | $1.8B | $65.5M | ||
| Q4 24 | $1.8B | $75.4M | ||
| Q3 24 | $1.8B | $84.4M | ||
| Q2 24 | $1.8B | $94.6M | ||
| Q1 24 | $1.4B | $105.9M |
总资产BRKRRPID
| Q4 25 | $6.2B | $74.9M | ||
| Q3 25 | $6.4B | $84.4M | ||
| Q2 25 | $6.3B | $75.6M | ||
| Q1 25 | $5.9B | $85.4M | ||
| Q4 24 | $5.8B | $98.2M | ||
| Q3 24 | $6.1B | $105.8M | ||
| Q2 24 | $5.9B | $117.1M | ||
| Q1 24 | $4.5B | $127.7M |
负债/权益比BRKRRPID
| Q4 25 | 0.76× | — | ||
| Q3 25 | 0.83× | — | ||
| Q2 25 | 1.34× | — | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 1.18× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.97× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $229.8M | $-3.2M |
| 自由现金流经营现金流 - 资本支出 | $207.2M | $-3.3M |
| 自由现金流率自由现金流/营收 | 21.2% | -29.6% |
| 资本支出强度资本支出/营收 | 2.3% | 0.8% |
| 现金转化率经营现金流/净利润 | 8.84× | — |
| 过去12个月自由现金流最近4个季度 | $43.3M | $-31.9M |
8季度趋势，按日历期对齐
经营现金流BRKRRPID
| Q4 25 | $229.8M | $-3.2M | ||
| Q3 25 | $-33.2M | $-9.1M | ||
| Q2 25 | $-127.5M | $-9.7M | ||
| Q1 25 | $65.0M | $-9.1M | ||
| Q4 24 | $190.0M | $-9.9M | ||
| Q3 24 | $38.4M | $-8.6M | ||
| Q2 24 | $1.1M | $-10.1M | ||
| Q1 24 | $21.8M | $-15.5M |
自由现金流BRKRRPID
| Q4 25 | $207.2M | $-3.3M | ||
| Q3 25 | $-54.1M | $-9.1M | ||
| Q2 25 | $-148.8M | $-10.1M | ||
| Q1 25 | $39.0M | $-9.4M | ||
| Q4 24 | $153.3M | $-10.0M | ||
| Q3 24 | $5.8M | $-8.8M | ||
| Q2 24 | $-23.5M | $-10.6M | ||
| Q1 24 | $400.0K | $-16.1M |
自由现金流率BRKRRPID
| Q4 25 | 21.2% | -29.6% | ||
| Q3 25 | -6.3% | -116.4% | ||
| Q2 25 | -18.7% | -138.6% | ||
| Q1 25 | 4.9% | -130.2% | ||
| Q4 24 | 15.6% | -121.8% | ||
| Q3 24 | 0.7% | -116.0% | ||
| Q2 24 | -2.9% | -159.8% | ||
| Q1 24 | 0.1% | -287.1% |
资本支出强度BRKRRPID
| Q4 25 | 2.3% | 0.8% | ||
| Q3 25 | 2.4% | 0.9% | ||
| Q2 25 | 2.7% | 5.0% | ||
| Q1 25 | 3.2% | 4.4% | ||
| Q4 24 | 3.7% | 1.2% | ||
| Q3 24 | 3.8% | 2.9% | ||
| Q2 24 | 3.1% | 6.9% | ||
| Q1 24 | 3.0% | 10.4% |
现金转化率BRKRRPID
| Q4 25 | 8.84× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -16.78× | — | ||
| Q1 25 | 3.74× | — | ||
| Q4 24 | 13.87× | — | ||
| Q3 24 | 0.94× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.43× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRKR
| Bsi Nano | $309.1M | 32% |
| Bsi Biospin | $267.0M | 27% |
| Other | $179.9M | 18% |
| Transferred Over Time | $142.5M | 15% |
| Energy And Supercon Technologies | $69.5M | 7% |
RPID
| Products | $9.3M | 83% |
| Services | $2.0M | 17% |
